Literature DB >> 26241292

ESCAPE ancillary blood pressure measurement study 2: changes in end-digit preference after 2 years of a cluster randomized trial.

Clarisse Dibao-Dina1, Jean-Pierre Lebeau, Dominique Huas, Florent Boutitie, Denis Pouchain.   

Abstract

OBJECTIVE: The aim of the ESCAPE AMPA 2 trial was to describe the evolution of end-digit preference (EDP) practices in primary care after 2 years of trial.
METHODS: A descriptive analysis of the EDP in the intervention group (IG) and in the electronic control group (ECG) of the ESCAPE trial and a comparative analysis of EDP changes in blood pressure (BP) measures of both groups were carried out between baseline and 2 years. In the ESCAPE trial, physicians in the IG were new users of electronic devices provided in the trial to measure their patients' BP and physicians in the ECG were former users of electronic devices. Hierarchical mixed-effects models were used for statistical analysis in a pragmatic cluster randomized-controlled trial.
RESULTS: After 2 years, the proportion of BP measures ending with a 0 or a 5 was significantly higher in the ECG than in the IG (50.4 vs. 33.4%, P<0.0001). There was no significant change in EDP tendency between baseline and the end of the trial in the ECG (65.6-56.7%, P=0.39) and in the IG (29.6-38.2%, P=0.07), with a between-groups P value of 0.11. Over 2 years, there was no significant change in systematic EDP in the ECG (18.8-20.0%, P=0.29) and in the IG (4.8-10.6%, P=0.01), with a between-groups P value of 0.17.
CONCLUSION: EDP is not eliminated by electronic devices and tends to increase with time for new users.

Entities:  

Mesh:

Year:  2015        PMID: 26241292     DOI: 10.1097/MBP.0000000000000144

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  1 in total

1.  Are self-reported telemonitored blood pressure readings affected by end-digit preference: a prospective cohort study in Scotland.

Authors:  Richard A Parker; Mary Paterson; Paul Padfield; Hilary Pinnock; Janet Hanley; Vicky S Hammersley; Adam Steventon; Brian McKinstry
Journal:  BMJ Open       Date:  2018-01-31       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.